(Red Cross Global HIV Program)
Dr Jonathan Anderson
(ViiV Healthcare Australia, a joint venture by GlaxoSmithKline and Pfizer)
(journalist, editor, policy analyst and advocate for HIV/AID prevention)
How do we begin combating the HIV/AIDS epidemic, and what progress has been made so far? This panel discussion explores the current issues facing the prevention and treatment of HIV/AIDs as well as the progress being made every day in eradicating the disease.
||12:00pm-1:00pm, Monday, 23 August 2010
||Pharmacy Lecture Theatre
||Please email firstname.lastname@example.org
About the Speakers
was a volunteer in the early HIV response in Australia and served two term as Vice President of the Victorian AIDS Council, and then was later its General Manager for three years. He managed the HIV Unit of the Victorian Human Services Department and chaired the 1st national conference of the Chronic Illness Alliance. His overseas work has been within the Red Cross Movement, first as Manager of the Australian Red Cross HIV Programme in East and South-East Asia for five years based in Bangkok, and then 7 years based in Geneva as Manager of the International Federation of Red Cross and Red Crescent Societies Global HIV Programme. He has visited more than 50 countries to assist with HIV programming, and during his tenure the Red Cross HIV work expanded from $3 million per year to over $100 million per year.
Dr Jonathan Anderson
is the Medical Director of ViiV Healthcare Australia, a joint venture by GlaxoSmithKlein and Pfizer that is 100% focused on treatment and care of HIV. He was a primary care doctor with a special interest in HIV, sexual health and gay men’s health at the Carlton & Northside clinics in Melbourne from 1993-2010. As an active member of the National Centre in HIV Epidemiology and Clinical Research network, he was involved in multiple clinical research studies and helped found the Australian HIV Observational Database. He was President of the Australasian Society for HIV Medicine and member of the Federal and state ministerial advisory committees. In 2004 he worked in Botswana for the African Comprehensive HIV/AIDS Development Partnership (ACHAP) a collaboration between the government of Botswana and the Gates Foundation. Currently, Jonathan is an Adjunct Associate Professor at Sydney Medical School and is the author of 26 peer-reviewed publications on HIV treatment and care, health economics, HPV and pandemic influenza.
has worked in the HIV community sector for more than 15 years as a journalist, editor, policy analyst and advocate. She sits on the steering committee of the International Rectal Microbicides Advocates and is a graduate of the University of Sydney's Masters of Bioethics program. Bridget works as Senior Policy Analyst for Family Planning NSW and is completing a PhD in Bioethics at the Centre for Values, Ethics and the Law in Medicine, University of Sydney.